1-17 Current Status of Sublingual Immunotherapy in the United States

Friday, 13 December 2013: 13:55 - 14:15
Great Lakes Grand Ballroom West (Westin - Michigan Avenue)
• WAO_SLIT_Chicago_Final.pdf

Michael Blaiss, MD , Pediatrics and Medicine, University of Tennessee Health Science Center

Learning Objectives:
State and discuss the successful trials of SLIT in both the United  States and Europe.
See more of: Sublingual Immunotherapy
See more of: Immunotherapy Track
<< Previous Presentation | Next Presentation >>